on GUERBET (EPA:GBT)
Guerbet Announces Interim CEO Amid Leadership Change
Villepinte, France, September 22, 2025: Guerbet, known for its expertise in contrast agents and solutions for medical imaging, has appointed Jérôme Estampes as interim Chief Executive Officer. Estampes succeeds David Hale, who is leaving the group for new ventures. Hale served Guerbet since February 2018, initially as Chief Commercial Officer and later as CEO from January 2020.
Jérôme Estampes joined Guerbet in 2019 as Chief Administrative and Financial Officer, managing IT, business development, and licensing. His experience has provided him with insights into Guerbet’s financial and operational landscape, which he will leverage during this transition. Supported by the Board, Estampes aims to ensure continuity and the execution of transformative strategies.
The search for a new permanent CEO is underway, as confirmed by Guerbet's Nominations and Remuneration Committee. In related news, the company will release its 2025 First Half Results on September 24, after the market closes.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all GUERBET news